Join Lifebit’s upcoming webinar The Future of Target Validation to hear from global life sciences and genomics expert Dr Jeffrey Gulcher on the transformative impact of molecular data in streamlining and delivering successful target validation.

The pharmaceutical industry is vital in providing life-saving therapeutics worldwide. However, the growing global population, coupled with the prevalence of chronic conditions, intensifies the demand for large-scale and fast clinical discovery and production. 

Our webinar will explore the pivotal role of deep, diverse genomic data in delivering fast and effective target validation and replication, and subsequent clinical trial optimization. From providing an evidence base for selecting pre-clinical candidates to optimizing a cohort that matches target trials, large scale, diverse data provides the solution.